Mineralys Therapeutics (MLYS) Prepaid Assets (2022 - 2026)
Mineralys Therapeutics (MLYS) reported Prepaid Assets of $6.4 million for Q1 2026, down 44.16% on a YoY basis from $11.5 million in Q1 2025, and up 34.92% sequentially from $4.8 million in Q4 2025.
Mineralys Therapeutics (MLYS) Prepaid Assets (2022 - 2026) Analysis & Trends
Mineralys Therapeutics (MLYS) has 5 years of Prepaid Assets data on file, last reported at $6.4 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 44.16% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (down 44.16% YoY), and the FY2025 full-year result was $4.8 million, down 33.68% from the prior year.
- Prepaid Assets climbed to $6.4 million in Q1 2026, from $4.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $12.5 million in Q4 2023 to a low of $2.7 million in Q4 2022.
- A 5-year average of $7.5 million and a median of $7.0 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 364.12% in 2023 and plunged 64.45% in 2024, its largest moves.
- Tracing MLYS's Prepaid Assets over 5 years: stood at $2.7 million in 2022, then jumped by 364.12% to $12.5 million in 2023, then plunged by 42.85% to $7.2 million in 2024, then slumped by 33.68% to $4.8 million in 2025, then soared by 34.92% to $6.4 million in 2026.
- Business Quant data shows MLYS's Prepaid Assets at $6.4 million in Q1 2026, $4.8 million in Q4 2025, and $6.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mineralys Therapeutics | 2.24 Bn | 2.24 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.41 Mn |
| Dec 31, 2025 | 4.75 Mn |
| Sep 30, 2025 | 6.17 Mn |
| Jun 30, 2025 | 10.35 Mn |
| Mar 31, 2025 | 11.48 Mn |
| Dec 31, 2024 | 7.16 Mn |
| Sep 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 6.89 Mn |
| Mar 31, 2024 | 8.25 Mn |
| Dec 31, 2023 | 12.54 Mn |
| Sep 30, 2023 | 11.61 Mn |
| Jun 30, 2023 | 8.39 Mn |
| Mar 31, 2023 | 4.64 Mn |
| Dec 31, 2022 | 2.70 Mn |